TE_8637
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | Charlie1 |
|---|---|
| TE superfamily | Charlie |
| TE class | DNA |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.06 |
| Counts of samples | TCGA_tumor:109; TCGA_normal:91; GTEx:2063 |
| TSS | chr3(-):126269518 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_8637.1 | - | Intergenic | Non-coding | Non-coding | chr3(-):126268876,126268896,126269267,126269519 |
| teRNA_8637.2 | - | Intergenic | Non-coding | Non-coding | chr3(-):126267473,126267493,126268781,126268896,126269267,126269519 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
